Imatinib-induced ophthalmological side-effects in GIST patients are associated with the variations of EGFR, SLC22A1, SLC22A5 and ABCB1

Imatinib-induced ophthalmological side-effects in GIST patients are associated with the variations of EGFR, SLC22A1, SLC22A5 and ABCB1

The Pharmacogenomics Journal advance online publication, August 1 2017.
doi:10.1038/tpj.2017.40

Authors: H-B Qiu, W Zhuang, T Wu, S Xin, C-Z Lin, H-L Ruan, X Zhu, M Huang, J-L Li, X-Y Hou, Z-W Zhou & X-D Wang

Source: The Pharmacogenomics Journal - August 1, 2017 Category: Drugs & Pharmacology Authors: H-B Qiu W Zhuang T Wu S Xin C-Z Lin H-L Ruan X Zhu M Huang J-L Li X-Y Hou Z-W Zhou X-D Wang Source Type: research